Phase 1 human clinical trial for an antisera has been permitted by the Drugs Controller General of India (DCGI). The ‘antisera’ was developed by injecting inactivated SARS-CoV-2 virus in horses, and is believed to be a potential Covid-19 treatment, as relayed by ICMR officials. ICMR (Indian Council of Medical Research) has developed the antisera in ...